OpenAI acquires startup Orchestra Bio⁠ to beef up its biotech business

In Brief

OpenAI connected Tuesday acquired a four-year-old AI biotech bundle startup called Orchestra Bio, the institution announced via its website. Terms of the woody were not disclosed, but the startup had reportedly raised around $20 million arsenic of 2025 from backers similar Andreessen Horowitz, Atria, and 8VC.

Orchestra creates AI agents that assistance biotech companies negociate the minutiae of cause find operations, from tracking finances to resolving scheduling issues with objective trials.

OpenAI says it’s adding Orchestra’s squad and exertion to enactment connected Rosalind, its AI exemplary for beingness sciences research, and to its related Rosalind Workbench tool, a harness that aims to assistance researchers program experiments and analyse results. OpenAI has already won immoderate large names arsenic customers for Rosalind, including, it says, Moderna⁠ and Novo Nordisk⁠.

The acquisition is simply a classical illustration of however the biggest AI labs (namely OpenAI and Anthropic) are gathering ever much bundle for the biggest industries, similar pharma. In the startup world, determination is an ongoing fearfulness that astatine immoderate moment, the labs volition motorboat caller features and go competitors. In this case, Orchestra is getting absorbed, alternatively than stomped out.

Subscribe for the industry’s biggest tech news